title: Local and intralesional therapy of in-transit melanoma metastases.
abstract: Regional relapse of melanoma may occur as satellite or in-transit metastases proximal to the primary tumor in the direction of the lymph flow. The management of in-transit metastases is challenging because the efficacy of treatment is largely dictated by the biological behavior of the patient's melanoma. This review examines local treatment modalities.
authors.affiliation: Melanoma and Sarcoma Division, European Institute of Oncology, Milan, Italy. alessandro.testori@ieo.it
authors.forename: Alessandro
authors.initials: A
authors.lastname: Testori
authors.forename: Mark B
authors.initials: MB
authors.lastname: Faries
authors.forename: John F
authors.initials: JF
authors.lastname: Thompson
authors.forename: E
authors.initials: E
authors.lastname: Pennacchioli
authors.forename: Jan P
authors.initials: JP
authors.lastname: Deroose
authors.forename: Albertus N
authors.initials: AN
authors.lastname: van Geel
authors.forename: Cornelis
authors.initials: C
authors.lastname: Verhoef
authors.forename: Francesco
authors.initials: F
authors.lastname: Verrecchia
authors.forename: Javier
authors.initials: J
authors.lastname: Soteldo
mesh_terms: D000287:Administration, Topical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016207:Cytokines / Q000008:administration & dosage; D053672:Electrochemotherapy; D006801:Humans; D007167:Immunotherapy; D015552:Injections, Intralesional; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000556:secondary / Q000628:therapy*; D009163:Mycobacterium bovis; D011878:Radiotherapy; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D016207:Cytokines